ETADX
Price
$19.59
Change
+$0.10 (+0.51%)
Updated
Jul 3 closing price
Net Assets
1.21B
VIMSX
Price
$77.52
Change
+$0.46 (+0.60%)
Updated
Jul 3 closing price
Net Assets
185.28B
Interact to see
Advertisement

ETADX vs VIMSX

Header iconETADX vs VIMSX Comparison
Open Charts ETADX vs VIMSXBanner chart's image
Eventide Dividend Growth A
Price$19.59
Change+$0.10 (+0.51%)
VolumeN/A
Net Assets1.21B
Vanguard Mid Cap Index Investor
Price$77.52
Change+$0.46 (+0.60%)
VolumeN/A
Net Assets185.28B
ETADX vs VIMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ETADX vs. VIMSX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETADX is a Buy and VIMSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 185B vs. ETADX (1.21B). VIMSX pays higher dividends than ETADX: VIMSX (1.40) vs ETADX (0.45). ETADX was incepted earlier than VIMSX: ETADX (8 years) vs VIMSX (27 years). ETADX (1.21) is less costly to investors than VIMSX (0.17). ETADX is a more actively managed with annual turnover of: 38.00 vs. VIMSX (16.00). ETADX has a lower initial minimum investment than VIMSX: ETADX (1000) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 17.63 vs. ETADX (10.62). ETADX return over 5 years is better than : 85.32 vs. VIMSX (73.64).
ETADXVIMSXETADX / VIMSX
Total Expense Ratio1.200.17706%
Annual Report Gross Expense Ratio1.210.17712%
Fund Existence8 years27 years-
Gain YTD5.0907.62567%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.21B185B1%
Annual Yield % from dividends0.451.4032%
Returns for 1 year10.6217.6360%
Returns for 3 years46.6243.06108%
Returns for 5 years85.3273.64116%
Returns for 10 yearsN/A127.44-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MYRG188.885.60
+3.06%
MYR Group
VRSN286.324.30
+1.52%
VeriSign
EVER24.530.34
+1.41%
EverQuote
BOLT5.92-0.08
-1.33%
Bolt Biotherapeutics Inc
SGMO0.53-0.01
-1.51%
Sangamo Therapeutics